Join @ArriVent BioPharma (#AVBP) for a virtual KOL event on Monday, Sep. 9 at 4:30 pm ET featuring Xiuning Le, MD, PhD (The University of Texas MD Anderson Cancer Center) to discuss the unmet need and current treatment landscape for non-small cell lung cancer (NSCLC) EGFR PACC mutations. Register here: https://lnkd.in/gB4rUZXB
This content isn’t available here
Access this content and more in the LinkedIn app